The Humanized Anti PD-1 Antibody, CT-011, Increases Specific CD4+Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell Transplantation (AuSCT).

被引:2
|
作者
Rotem-Yehudar, Rinat [1 ]
Armand, Philippe [2 ]
Devine, Steve [3 ]
Fay, Joseph W. [4 ]
Hosing, Chitra [5 ]
Mapara, Markus Y. [6 ,7 ]
Campagnero, Erica [8 ]
Uberti, Joseph P. [9 ]
Avigan, David [10 ]
Ballen, Karen K. [11 ]
Winter, Jane N.
Nagler, Arnon [13 ]
Gordon, Leo I. [12 ]
机构
[1] CureTech Ltd, IL-81227 Yavne, Israel
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Ohio State Univ, Columbus, OH 43210 USA
[4] Baylor Univ, Med Ctr, Dallas, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA USA
[7] Inst Canc Res, Pittsburgh, PA USA
[8] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
[9] Karmanos Canc Inst, Detroit, MI USA
[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[11] Massachusetts Gen Hosp, Boston, MA 02114 USA
[12] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA
[13] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel
关键词
D O I
10.1182/blood.V114.22.1216.1216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:500 / 501
页数:2
相关论文
共 33 条
  • [1] CT-011, a humanized monoclonal antibody, interacts with the PD-1 receptor and modulates survival and trafficking signals in effector/memory T lymphocytes
    Rotem-Yehudar, Rinat
    Rodionov, Galina
    Landes, Shimon
    CANCER RESEARCH, 2009, 69
  • [2] PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
    Frigault, Matthew J.
    Armand, Philippe
    Redd, Robert A.
    Jeter, Erin
    Merryman, Reid W.
    Coleman, Kimberly C.
    Herrera, Alex F.
    Dahi, Parastoo
    Nieto, Yago
    LaCasce, Ann S.
    Fisher, David C.
    Ng, Samuel Y.
    Odejide, Oreife O.
    Freedman, Arnold S.
    Kim, Austin, I
    Crombie, Jennifer L.
    Jacobson, Caron A.
    Jacobsen, Eric D.
    Wong, Jeffrey L.
    Bsat, Jad
    Patel, Sanjay S.
    Ritz, Jerome
    Rodig, Scott J.
    Shipp, Margaret A.
    Chen, Yi-Bin
    Joyce, Robin M.
    BLOOD ADVANCES, 2020, 4 (01) : 122 - 126
  • [3] PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation
    Chen, Yi-Bin
    Armand, Philippe
    Redd, Robert A.
    Bsat, Jad
    Merryman, Reid W.
    Coleman, Kimberly
    Herrera, Alex F.
    Dahi, Parastoo B.
    Nieto, Yago
    LaCasce, Ann S.
    Fisher, David C.
    Ng, Samuel Y.
    Odejide, Oreofe O.
    Freedman, Arnold S.
    Kim, Austin I.
    Crombie, Jennifer L.
    Jacobson, Caron A.
    Jacobsen, Eric D.
    Wong, Jeffrey L.
    Patel, Sanjay S.
    Ritz, Jerome
    Rodig, Scott J.
    Shipp, Margaret A.
    Joyce, Robin M.
    BLOOD, 2018, 132
  • [4] PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
    Rosenblatt, Jacalyn
    Glotzbecker, Brett
    Mills, Heidi
    Vasir, Baldev
    Tzachanis, Dimitrios
    Levine, James D.
    Joyce, Robin M.
    Wellenstein, Kerry
    Keefe, Whitney
    Schickler, Michael
    Rotem-Yehudar, Rinat
    Kufe, Donald
    Avigan, David
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (05) : 409 - 418
  • [5] Restoring Antitumor Immunity via PD-1 Blockade After Autologous Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma
    Jacobsen, Eric D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (33) : 4268 - +
  • [6] CT-011, ANTI PD-1 ANTIBODY, ENHANCES EX-VIVO T CELL RESPONSES TO AUTOLOGOUS DENDRITIC/MYELOMA FUSION VACCINE DEVELOPED FOR THE TREATMENT OF MULTIPLE MYELOMA
    Rosenblatt, J.
    Glotzbecker, B.
    Mills, H.
    Keefe, W.
    Wellenstein, K.
    Vasir, B.
    Wu, Z.
    Zarwan, C.
    Schickler, M.
    Rotem-Yehudar, R.
    Kufe, D.
    Avigan, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S237 - S237
  • [7] The Number of CD4+T-Lymphocytes in the Autograft Correlates with Outcome After Autologous Stem-Cell Transplantation in Relapsed Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
    Schaffel, Rony
    Lima, Maria L. S.
    Madureira, Adrienne B. M.
    Spector, Nelson
    Dutra, Helio S.
    BLOOD, 2009, 114 (22) : 1329 - 1329
  • [8] PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma
    Zhang, Wei
    Bai, Jie-Fei
    Zuo, Meng-Xuan
    Cao, Xin-Xin
    Chen, Miao
    Zhang, Yan
    Han, Xiao
    Zhong, Ding-Rong
    Zhou, Dao-Bin
    CANCER MEDICINE, 2016, 5 (11): : 3077 - 3084
  • [9] Prognostic value of pre-transplant FDG PET/CT Scan in patients with Diffuse Large B-Cell Lymphoma ((DLBCL) undergoing Autologous Stem Cell Transplantation (ASCT)
    Shah, Shetal
    Winter, Allison
    Rybicki, Lisa
    Hill, Brian
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [10] R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by autologous stem cell transplantation: CORAL study
    Gisselbrecht, C.
    Glass, B.
    Mounier, N.
    Gill, D.
    Linch, D.
    Trneny, M.
    Bosly, A.
    Shpilberg, O.
    Ketterer, N.
    Moskowitz, C.
    Schmitz, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)